The Asia Pacific Bone Densitometers Market would witness market growth of 6.4% CAGR during the forecast period (2018 – 2024). Bone densitometry technology is used to measure bone mass. It also helps with measuring the amount of bone mass that is deficient in a patient’s body. The Asia-Pacific region is projected to be the fastest growing region for the bone densitometer market during the prediction period. The growth is projected to be a result of high demand to curb the growing prevalence of healthcare facilities, increased disposable income, and better infrastructure. The bone densitometer industry will also present potential growth opportunities in a growing awareness of osteoporosis in emerging economies, like India and China. China, India, Japan, and South Korea, followed by the rest of Asia Pacific, are the major country-specific markets in the region.
Osteoporosis is a highly unrecognized and unaddressed problem and a major cause of fractures in developing countries such as India. This condition is marked by low bone mineral density (BMD), which is not screened regularly. Again, the prevalence of low BMD among adult populations in this part of the country is not widely reported. With increasing awareness and complication of the condition, early detection and treatment must be given particular attention.
Based on Technology, the market is segmented into DEXA (Dual Energy X-ray Absorptiometry), Ultrasound, and Other. Based on Application, the market is segmented into Central Scan and Peripheral Scan. Based on the End user, the market is segmented into Hospitals, Clinics and Other end users.. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Osteoporosis fractures in Asian countries, such as Japan, have become a major medical and economic burden. In Japan, BMD measures expressed as percentages of the young adult mean (YAM) for women are based on criteria for osteoporosis diagnosis prepared by the Japanese Society for Society for Bone and Mineral Research. A diagnosis of osteoporosis is made when the BMD is below 70 percent of the YAM in patients without a previous fragility fracture.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report General Electric (GE), Cooper Companies Inc., Hologic Inc., CompuMed, Inc., Digirad Corporation, BeamMed Ltd, Demetech AB, Lone Oak Medical Technologies LLC, OSI Systems, Inc and Swissray International Inc.